The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Dec 2020 12:38

RNS Number : 1668K
ADVFN PLC
30 December 2020
 

For immediate release 

30 December 2020

ADVFN PLC

("ADVFN" or the "Company")

Director / PDMR shareholding

 

The Board of ADVFN PLC announces that the Board has agreed to amend the terms of 1,222,946 options held by certain directors, in aggregate representing 4.76 per cent. of the issued share capital of the Company. The exercise price of the options has been re-set at 14p per new ordinary share (compared to a closing mid-market price of 11.5p on 29 December 2020). Prior to the amendment, the options had exercise prices substantially greater than the prevailing market price.

The table below sets out the amended options:

Director

Original grant date

M Hodges

C Chambers

 J Mullins

M Collom

Pre-amendment exercise price per share

Amended exercise price per share

27.01.04

40,000

60,000

40,000

0

118.75p

14p

27.01.05

40,000

60,000

40,000

0

115p

14p

06.09.06

60,000

60,000

60,000

0

82.5p

14p

21.10.09

31,473

31,473

0

0

76.4p

14p

12.12.14

200,000

200,000

100,000

200,000

79.5p

14p

The re-setting of the option exercise price was reviewed by the independent non-executive director of the Company, Mr Tom Spiller and approved on 29 December 2020. Other than an amendment to the exercise price, the terms of the options remain unaltered. Other than the options granted in 2014 (which lapse on 12 December 2024), the options set out in the table above will lapse unless exercised on or before 31 December 2022. No other options have been issued or amended in the prior 12-month period.

A copy of this announcement is available on the Company's website, at www.advfn.com

For further information please contact:

ADVFN PLC

Clem Chambers CEO

Tel: +44 20 3868 6702

 

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish

Tel: +44 (0) 207 628 3396

 

Cassiopeia Ltd (Investor Relations)

Stefania Barbaglio

stefania@cassiopeia-ltd.com

 The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Michael Hodges

2. Clem Chambers

3. Jonathan Mullins

4. Matthew Collom

2

 

Reason for the notification

 

a)

 

Position/

status

 

 

1. Chairman

2. Chief Executive

3. Director

4. Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ADVFN plc

b)

 

LEI

 

21380042SDV1E1ZVIY40

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.2p each ("Ordinary Shares")

Identification code

GB00BPT24C10

 

b)

 

Nature of the transaction

Amendment of exercise price of options over Ordinary Shares

c)

 

Price(s) and volume(s)

Director

Price payable on exercise of option

Volume(s)

 

Michael Hodges

£0.14

371,473

Clem Chambers

£0.14

411,473

Jonathan Mullins

£0.14

240,000

Matthew Collom

£0.14

200,000

d)

 

Aggregated information

- Aggregated volume

1,222,946 options over Ordinary Shares

- Price

Price payable on exercise of option - UK£0.14

e)

 

Date of the transaction

 

29 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLBLFXBLLFFBK
Date   Source Headline
14th Dec 20183:08 pmRNSResult of AGM
5th Nov 20187:00 amRNSFinal Results
2nd Oct 20184:40 pmRNSSecond Price Monitoring Extn
2nd Oct 20184:35 pmRNSPrice Monitoring Extension
21st Aug 20182:05 pmRNSSecond Price Monitoring Extn
21st Aug 20182:00 pmRNSPrice Monitoring Extension
18th Jun 201811:05 amRNSSecond Price Monitoring Extn
18th Jun 201811:00 amRNSPrice Monitoring Extension
18th Jun 20189:05 amRNSSecond Price Monitoring Extn
18th Jun 20189:00 amRNSPrice Monitoring Extension
14th Jun 20182:05 pmRNSSecond Price Monitoring Extn
14th Jun 20182:00 pmRNSPrice Monitoring Extension
8th Jun 20187:00 amRNSDirector/PDMR Shareholding
1st May 20188:30 amRNSCryptoCompare & MJAC London Blockchain Summit
18th Apr 20185:35 pmRNSCorporate Update
16th Mar 20182:02 pmRNSHalf-year Report
14th Mar 20187:00 amRNSADVFN International Financial Awards 2018: winners
9th Mar 20184:59 pmRNSAmended sale terms - Equity Holdings Limited
15th Dec 201711:48 amRNSResult of AGM
7th Dec 20177:00 amRNSPlusOneCoin cryptocurrency project
24th Nov 20174:15 pmRNSGrant of Options
20th Nov 201710:46 amRNSCorporate Update
16th Nov 20177:30 amRNSNew blockchain regulation advisory service
26th Oct 20177:00 amRNSAppointment of Nominated Adviser
23rd Oct 20175:37 pmRNSAudited Results for the Year Ended 30 June 2017
28th Jun 201712:53 pmRNSHolding(s) in Company
19th Jun 20174:36 pmRNSDirector/PDMR Shareholding
24th Mar 20175:00 pmRNSHalf-year Report
21st Mar 20177:00 amRNSADVFN International Financial Awards 2017
27th Feb 20172:40 pmRNSHolding(s) in Company
7th Feb 20177:30 amRNSADVFN's inside track on Brexit sensitive stocks
15th Dec 20164:19 pmRNSResult of AGM
10th Nov 20167:30 amRNSADVFN Books expands catalogue
21st Oct 20165:56 pmRNSAudited Results for the Year Ended 30 June 2016
11th Aug 20162:45 pmRNSDirector dealing and issue of equity
23rd Jun 201611:27 amRNSADVFN launches Follow Feed
28th Apr 20165:33 pmRNSReplacement: Director dealing and issue of equity
28th Apr 20169:22 amRNSDirector dealing and issue of equity
24th Mar 20165:45 pmRNSHalf Yearly Report
21st Mar 20165:19 pmRNSAgreement with businessagent.com
8th Mar 20167:00 amRNSADVFN International Financial Awards 2016 winners
28th Jan 20165:30 pmRNSResult of General Meeting
21st Dec 20155:07 pmRNSChange of Broker
18th Dec 20156:27 pmRNSResult of AGM
14th Dec 20155:01 pmRNSIssue of Equity
23rd Oct 20155:30 pmRNSAudited Results for the Year Ended 30 June 2015
29th Jun 20157:00 amRNSResponse to recent press speculation
23rd Jun 20157:05 amRNSHolding(s) in Company
3rd Jun 20155:40 pmRNSHolding(s) in Company
2nd Jun 20155:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.